BridgeMD
New treatment option for Dysphagia
Official title Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia
ClinicalTrials.gov ID: NCT05591040
What this study is testing
- What it's testing
- The aim of the study is to evaluate whether the effect of biofeedback treatment is more effective than a control treatment in the recovery of dysphagia. This study will be a multicentric randomized, single-blind controlled study.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 89
You may be able to join if
- first stroke injury
- onset from more than six weeks
- presence of dysphagia
- good comprehension ( not below PT 53 in Token Test)
- good eyesight and hearing, or adequately corrected
You likely can't join if
- All the elements that hinder a good recording of the electromyographic signal (for instance a cutaneous infection, a wound or a dermatitis in the...
- Severe concomitant illnesses (fever, infections, metabolic problems, serious cardiac insufficiency) that can influence patient's collaboration;
- Serious dystonia or unintentional movements
- presence of disorders of consciousness;
- encephalopathy due to multiple infarcts;
- inability to sustain the experimental treatment;
See the full eligibility criteria
- first stroke injury
- onset from more than six weeks
- presence of dysphagia
- good comprehension ( not below PT 53 in Token Test)
- good eyesight and hearing, or adequately corrected
- All the elements that hinder a good recording of the electromyographic signal (for instance a cutaneous infection, a wound or a dermatitis in the submandibular area);
- Severe concomitant illnesses (fever, infections, metabolic problems, serious cardiac insufficiency) that can influence patient's collaboration;
- Serious dystonia or unintentional movements
- presence of disorders of consciousness;
- encephalopathy due to multiple infarcts;
- inability to sustain the experimental treatment;
- other neurological diseases (for example Parkinson disease)
The study team makes the final eligibility decision.
Where it's taking place
- Venice-Lido, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 89 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Venice-Lido, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.